Draxxin is a critical antibiotic for treating bovine respiratory disease (BRD) and other infections in cattle․ Proper dosage ensures effectiveness and safety, with 2․5 mg/kg (1․1 mL/100 lbs) recommended․ Administered subcutaneously, it offers a reliable solution for farmers and veterinarians, with a maximum injection volume of 10 mL per site․ The Draxxin KP combination product adds anti-inflammatory benefits, enhancing treatment for BRD and fever․
Overview of Draxxin and Its Importance
Draxxin (tulathromycin) is a macrolide antibiotic specifically formulated for veterinary use, primarily in cattle․ It is essential for treating bacterial infections such as bovine respiratory disease (BRD) and foot rot, which are significant challenges in livestock production․ The medication works by inhibiting bacterial protein synthesis, effectively combating infections․ Its broad-spectrum activity makes it a reliable choice for farmers and veterinarians․ Draxxin is administered as a single subcutaneous injection, simplifying treatment and reducing stress on animals․ The product’s efficacy and convenience have made it a cornerstone in cattle healthcare, ensuring healthier herds and improved productivity․ Proper dosing is critical to maximize therapeutic benefits while minimizing risks, emphasizing the importance of adhering to guidelines․
Recommended Dosage Guidelines
The recommended dosage of Draxxin for cattle is 2․5 mg/kg (1․1 mL per 100 lbs) of body weight, administered as a single subcutaneous injection․ Maximum injection volume per site is 10 mL․
Standard Dosage Calculation
The standard dosage of Draxxin for cattle is calculated based on body weight․ The recommended dose is 2․5 mg of tulathromycin per kilogram of body weight, which is equivalent to 1․1 mL per 100 pounds of body weight․ To calculate the dose for an individual animal, divide the animal’s weight in pounds by 100 and multiply by 1․1 mL․ For example, a 500-pound animal would require 5․5 mL of Draxxin․ Always use a dosing chart or consult a veterinarian to ensure accurate calculation․ This ensures the correct volume is administered for optimal efficacy and safety․ Proper dosing helps prevent under- or over-treatment, which can affect treatment outcomes and animal health․ Always follow label instructions carefully․
Maximum Injection Volume per Site
The maximum injection volume per site for Draxxin in cattle is 10 mL․ This limit ensures safety and minimizes the risk of injection site reactions or discomfort․ Administering more than 10 mL at a single site can lead to localized irritation or reduced efficacy․ Always adhere to this guideline to maintain animal welfare and treatment effectiveness․ For animals requiring higher doses, divide the total volume into multiple injection sites to stay within the 10 mL per site limit․ This approach ensures proper drug distribution and minimizes potential side effects․ Always follow the recommended dosing guidelines and consult a veterinarian if unsure about injection procedures or volumes․
Administration Methods
Draxxin is administered subcutaneously, typically in the neck, as a single injection․ The recommended dosage is 2․5 mg/kg (1․1 mL/100 lbs)․ Do not exceed 10 mL per site․
Subcutaneous Injection Procedure
Draxxin is administered via subcutaneous injection, typically in the neck area․ Ensure the injection site is clean and free from contamination․ Using a sterile needle, insert it under the skin at a 45-degree angle․ Administer the calculated dose slowly to minimize discomfort․ The neck region is preferred due to its accessibility and reduced risk of nerve damage․ Always follow proper aseptic technique to prevent infection․ After injection, apply gentle pressure to the site to reduce swelling․ The procedure ensures the medication is effectively absorbed into the bloodstream, providing optimal therapeutic outcomes for conditions like bovine respiratory disease and foot rot․ Proper handling and administration are crucial for both animal safety and treatment efficacy․
Preferred Injection Site
The preferred injection site for Draxxin in cattle is the subcutaneous tissue of the neck․ This area is ideal due to its accessibility and reduced risk of nerve or muscle damage․ Ensure the injection is administered high on the neck, avoiding the brisket or shoulder areas․ The subcutaneous tissue in the neck provides optimal absorption of the medication․ Always use a sterile needle and follow proper aseptic technique to minimize the risk of infection․ The neck area is recommended for both Draxxin and the Draxxin KP combination product․ Avoid injecting in areas with excessive fat or muscle, as this can lead to reduced efficacy or increased risk of complications․ The neck site ensures the medication is delivered effectively, enhancing therapeutic outcomes for conditions like BRD and foot rot․
Detailed Dosing Chart
| Animal Weight (lbs) | Dose Volume (mL) |
|---|---|
| 100 | 1․1 |
| 200 | 2․3 |
| 300 | 3․4 |
Table provides precise dosing guidelines based on animal weight, ensuring accurate administration of Draxxin for optimal therapeutic effectiveness in cattle․
Weight-Based Dosage Table
| Animal Weight (lbs) | Dose Volume (mL) |
|---|---|
| 100 | 1․1 |
| 200 | 2․3 |
| 300 | 3․4 |
This table provides a clear weight-based dosage guide for Draxxin administration in cattle․ The recommended dose is 2․5 mg/kg (1․1 mL/100 lbs), administered subcutaneously․ Ensure the dose does not exceed 10 mL per injection site for optimal efficacy and safety․ Always consult a veterinarian for accurate dosing based on individual animal weight and health conditions․ This table simplifies the calculation process, ensuring precise administration for effective treatment of bovine respiratory disease and other infections․ Proper dosing is crucial for therapeutic success and minimizing potential side effects․ Adhere to the guidelines to maximize treatment outcomes in your cattle․
Special Considerations
The safety of Draxxin in pregnant or lactating cattle has not been established․ Use only under veterinary guidance․ Ensure the maximum injection volume of 10 mL per site is not exceeded․ Draxxin KP, a combination product with ketoprofen, offers additional anti-inflammatory benefits for BRD treatment․ Always follow label instructions and consult a veterinarian for specific cases․ Proper administration ensures efficacy and minimizes potential side effects․ Safety precautions and dosage accuracy are critical for optimal outcomes in cattle health management․ Adhere to guidelines to avoid adverse reactions and ensure therapeutic success․
Draxxin KP Combination Product
Draxxin KP is an advanced combination product designed for treating bovine respiratory disease (BRD) and controlling associated fever․ It combines tulathromycin, a broad-spectrum macrolide antibiotic, with ketoprofen, a non-steroidal anti-inflammatory drug (NSAID)․ This dual-action formulation addresses both bacterial infection and inflammation, providing comprehensive care․ The recommended dosage is 2․5 mg tulathromycin and 3 mg ketoprofen per kilogram of body weight, equivalent to 1․1 mL per 100 lbs․ It is administered subcutaneously in the neck, with a maximum injection volume of 11․5 mL per site․ Draxxin KP offers a convenient, single-dose solution for farmers and veterinarians, enhancing treatment efficacy and improving animal recovery rates․ Its combination therapy is particularly effective in managing complex BRD cases, making it a valuable tool in cattle healthcare․
Safety Precautions
When using Draxxin, it is essential to follow safety guidelines to ensure the well-being of both animals and handlers․ The product has not been established as safe for use during pregnancy or lactation in cattle, so its administration during these periods should be based on a benefit/risk assessment by a veterinarian․ Additionally, care should be taken to avoid accidental self-injection or exposure․ The product may cause irritation or allergic reactions in sensitive individuals․ Proper handling and disposal procedures should be followed to minimize environmental impact․ Adherence to the recommended dosage and administration guidelines is critical to avoid adverse effects․ Always wear protective gloves and eyewear when handling the product, and wash hands thoroughly afterward․